サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1433372

更年期障害の世界市場：2023年～2030年

Global Menopause Market 2023-2030

出版日
ページ情報
英文 240 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=143.57円
更年期障害の世界市場：2023年～2030年
出版日: 2023年12月21日
発行: Orion Market Research
ページ情報: 英文 240 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の更年期障害市場規模、シェア、動向：治療薬別（栄養補助食品、OTC医薬品、ホルモン剤、非ホルモン剤）、投与経路別（局所、注射、経口）、流通チャネル別（施設販売、小売販売、オンライン販売）分析レポート、予測期間（2023年～2030年）

世界の更年期障害市場は予測期間（2023年～2030年）にCAGR 5.37％で成長すると予測されます。市場の成長はヘルスケア支出の増加に起因しています。健康とウェルビーイングへの注目が高まる中、更年期管理・緩和製品やサービスへの支出が増加しています。例えば、2023年7月、Slimming Sprinklesは、更年期の女性に正確でよく調査された情報を提供するために、更年期周辺、更年期、または閉経後でホルモンや生理的な大きな変化を経験している女性専用に設計された包括的な新しいオンラインプラットフォームを立ち上げました。

セグメント別の展望

更年期障害の世界市場では、栄養補助食品が大きなシェアを占めると予想されます。

治療の中でも、栄養補助食品サブセグメントが世界の更年期障害市場でかなりのシェアを占めると予想されます。このセグメントの成長は、消費者の嗜好に起因しています。特に更年期女性の間では、自然療法や植物療法が人気を集めています。マルチシステムの利点を提供し、天然源から生産されるサプリメントは、この層から頻繁に温かく受け入れられています。例えば、2022年10月、PharmaLineaは先進的な「全身」更年期サプリメントを発売しました。このサプリメントは、心臓、代謝、脳、骨の健康に役立つだけでなく、痛みを和らげる効果もあります。このことは、エストロゲンの減少によって影響を受けるさまざまな身体系に効果が期待できる、更年期障害に効果的なサプリメントであることを示しています。

地域別の展望

世界の更年期障害市場はさらに、北米（米国、カナダ）、欧州（英国、イタリア、スペイン、ドイツ、フランス、および欧州のその他地域）、アジア太平洋地域（インド、中国、日本、韓国、アジアのその他地域）、およびその他の地域（中東・アフリカ、ラテンアメリカ）を含む地域に基づいてセグメント化されます。中でもアジア太平洋地域は、発展途上国と先進国の両方を含むカテゴリーであることから、世界全体で大きなシェアを占めると予想されています。医療費の増加は、この業界に拍車をかけると予測されている。日本のような高齢化が進む国の発展は、この地域の市場を牽引すると予想されます。

北米地域は世界の更年期障害市場でかなりのCAGRで成長する見込み

すべての地域の中で、北米地域は予測期間中にかなりのCAGRで成長すると予想されています。この地域の成長は、健康とウェルネスに対する意識に起因しています。個人の健康意識が高まり、年齢を重ねても満足のいく生活水準を維持するための戦略を模索する中で、更年期関連の健康製品やサービスへの関心が高まっており、この傾向は更年期障害市場を前進させています。グローバルパブリックヘルスによると、2020年11月、先進国の平均閉経年齢は51歳、平均寿命は80.8歳である。つまり、女性は寿命の約3分の1を閉経後に費やすことになる。アメリカでは毎日約6,000人の女性が閉経を迎え、毎年約200万人が閉経を迎えている。

目次

第1章 レポート概要

  • 業界の現状分析と成長ポテンシャルの展望
  • 調査方法とツール
  • 市場内訳
    • セグメント別
    • 地域別

第2章 市場概要と洞察

  • 調査範囲
  • アナリストの洞察と現在の市場動向
    • 主な調査結果
    • 推奨事項
    • 結論

第3章 競合情勢

  • 主要企業分析
  • Abbott Healthcare Pvt.ltd.
    • 概要
    • 財務分析
    • SWOT分析
    • 最近の動向
  • AbbVie
    • 概要
    • 財務分析
    • SWOT分析
    • 最近の動向
  • At F. Hoffmann-La Roche Ltd
    • 概要
    • 財務分析
    • SWOT分析
    • 最近の動向
  • 主要戦略分析

第2章 市場セグメンテーション

  • 更年期障害の世界市場：治療薬別
    • 栄養補助食品
    • OTC医薬品
      • ホルモン剤
      • 非ホルモン
  • 更年期障害の世界市場：投与経路別
    • 局所
    • 注射剤
    • 経口
  • 更年期障害の世界市場：流通チャネル別
    • 機関販売
    • 小売販売
    • オンライン販売

第3章 地域分析

  • 北米
    • 米国
    • カナダ
  • 欧州
    • 英国
    • ドイツ
    • イタリア
    • スペイン
    • フランス
    • その他欧州
  • アジア太平洋
    • 中国
    • インド
    • 日本
    • 韓国
    • その他アジア太平洋
  • 世界のその他の地域

第4章 企業プロファイル

  • Bayer AG
  • Bionova
  • Biosante
  • Church & Dwight Co., Inc.
  • Dr.Reddy's Laboratories Ltd.
  • Duchesnay
  • Eli Lilly and Company India Pvt. Ltd.
  • Merck & Co., Inc.
  • Novo Nordisk A/S
  • Padagis US LLC
  • Pfizer
  • Procter & Gamble
  • Pure Encapsulations
  • Teva Pharmaceutical Industries Ltd.
  • Theramex HQ UK Ltd.
図表

LIST OF TABLES

  • 1. GLOBAL MENOPAUSE MARKET RESEARCH AND ANALYSIS BY TREATMENT, 2022-2030 ($ MILLION)
  • 2. GLOBAL DIETARY SUPPLEMENTS MENOPAUSE MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 3. GLOBAL OTC PHARMA PRODUCTS MENOPAUSE MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 4. GLOBAL HORMONAL MENOPAUSE MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 5. GLOBAL NON-HORMONAL MENOPAUSE MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 6. GLOBAL MENOPAUSE MARKET RESEARCH AND ANALYSIS BY ROUTE OF ADMINISTRATION , 2022-2030 ($ MILLION)
  • 7. GLOBAL MENOPAUSE TOPICAL MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 8. GLOBAL MENOPAUSE INJECTABLE MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 9. GLOBAL MENOPAUSE ORAL MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 10. GLOBAL MENOPAUSE MARKET RESEARCH AND ANALYSIS BY DISTRIBUTION CHANNEL, 2022-2030 ($ MILLION)
  • 11. GLOBAL MENOPAUSE FOR INSTITUTIONAL SALES MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 12. GLOBAL MENOPAUSE FOR RETAIL SALES MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 13. GLOBAL MENOPAUSE FOR ONLINE SALES MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 14. GLOBAL MENOPAUSE MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 15. NORTH AMERICAN MENOPAUSE MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
  • 16. NORTH AMERICAN MENOPAUSE MARKET RESEARCH AND ANALYSIS BY TREATMENT, 2022-2030 ($ MILLION)
  • 17. NORTH AMERICAN MENOPAUSE MARKET RESEARCH AND ANALYSIS BY ROUTE OF ADMINISTRATION,2022-2030 ($ MILLION)
  • 18. NORTH AMERICAN MENOPAUSE MARKET RESEARCH AND ANALYSIS BY DISTRIBUTION CHANNEL, 2022-2030 ($ MILLION)
  • 19. EUROPEAN MENOPAUSE MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
  • 20. EUROPEAN MENOPAUSE MARKET RESEARCH AND ANALYSIS BY TREATMENT, 2022-2030 ($ MILLION)
  • 21. EUROPEAN MENOPAUSE MARKET RESEARCH AND ANALYSIS BY ROUTE OF ADMINISTRATION, 2022-2030 ($ MILLION)
  • 22. EUROPEAN MENOPAUSE MARKET RESEARCH AND ANALYSIS BY DISTRIBUTION CHANNEL, 2022-2030 ($ MILLION)
  • 23. ASIA-PACIFIC MENOPAUSE MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
  • 24. ASIA-PACIFIC MENOPAUSE MARKET RESEARCH AND ANALYSIS BY TREATMENT, 2022-2030 ($ MILLION)
  • 25. ASIA-PACIFIC MENOPAUSE MARKET RESEARCH AND ANALYSIS BY ROUTE OF ADMINISTRATION, 2022-2030 ($ MILLION)
  • 26. ASIA-PACIFIC MENOPAUSE MARKET RESEARCH AND ANALYSIS BY DISTRIBUTION CHANNEL, 2022-2030 ($ MILLION)
  • 27. REST OF THE WORLD MENOPAUSE MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 28. REST OF THE WORLD MENOPAUSE MARKET RESEARCH AND ANALYSIS BY TREATMENT, 2022-2030 ($ MILLION)
  • 29. REST OF THE WORLD MENOPAUSE MARKET RESEARCH AND ANALYSIS BY ROUTE OF ADMINISTRATION,2022-2030 ($ MILLION)
  • 30. REST OF THE WORLD MENOPAUSE MARKET RESEARCH AND ANALYSIS BY DISTRIBUTION CHANNEL, 2022-2030 ($ MILLION)

LIST OF FIGURES

  • 1. GLOBAL MENOPAUSE MARKET SHARE BY TREATMENT, 2022 VS 2030 (%)
  • 2. GLOBAL DIETARY SUPPLEMENTS MENOPAUSE MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 3. GLOBAL OTC PHARMA PRODUCTS MENOPAUSE MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 4. GLOBAL HORMONAL MENOPAUSE MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 5. GLOBAL NON-HORMONAL MENOPAUSE MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 6. GLOBAL MENOPAUSE MARKET SHARE BY ROUTE OF ADMINISTRATION, 2022 VS 2030 (%)
  • 7. GLOBAL MENOPAUSE TOPICAL MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 8. GLOBAL MENOPAUSE INJECTABLE MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 9. GLOBAL MENOPAUSE ORAL MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 10. GLOBAL MENOPAUSE MARKET SHARE BY DISTRIBUTION CHANNEL, 2022 VS 2030 (%)
  • 11. GLOBAL MENOPAUSE FOR INSTITUTIONAL SALES MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 12. GLOBAL MENOPAUSE FOR RETAIL SALES MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 13. GLOBAL MENOPAUSE FOR ONLINE SALES MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 14. GLOBAL MENOPAUSE MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 15. US MENOPAUSE MARKET SIZE, 2022-2030 ($ MILLION)
  • 16. CANADA MENOPAUSE MARKET SIZE, 2022-2030 ($ MILLION)
  • 17. UK MENOPAUSE MARKET SIZE, 2022-2030 ($ MILLION)
  • 18. FRANCE MENOPAUSE MARKET SIZE, 2022-2030 ($ MILLION)
  • 19. GERMANY MENOPAUSE MARKET SIZE, 2022-2030 ($ MILLION)
  • 20. ITALY MENOPAUSE MARKET SIZE, 2022-2030 ($ MILLION)
  • 21. SPAIN MENOPAUSE MARKET SIZE, 2022-2030 ($ MILLION)
  • 22. REST OF EUROPE MENOPAUSE MARKET SIZE, 2022-2030 ($ MILLION)
  • 23. INDIA MENOPAUSE MARKET SIZE, 2022-2030 ($ MILLION)
  • 24. CHINA MENOPAUSE MARKET SIZE, 2022-2030 ($ MILLION)
  • 25. JAPAN MENOPAUSE MARKET SIZE, 2022-2030 ($ MILLION)
  • 26. SOUTH KOREA MENOPAUSE MARKET SIZE, 2022-2030 ($ MILLION)
  • 27. REST OF ASIA-PACIFIC MENOPAUSE MARKET SIZE, 2022-2030 ($ MILLION)
  • 28. REST OF THE WORLD MENOPAUSE MARKET SIZE, 2022-2030 ($ MILLION)
目次
Product Code: OMR2027953

Global Menopause Market Size, Share & Trends Analysis Report by Treatment (Dietary Supplements, OTC Pharma Products, Hormonal, and Non-hormonal), by Route of Administration (Topical, Injectable, and Oral), and by Distribution Channel (Institutional Sales, Retail Sales, and Online Sales), Forecast Period (2023-2030)

The global menopause market is anticipated to grow at a CAGR of 5.37 % during the forecast period (2023-2030). The market's growth is attributed to increasing healthcare expenditure. With an increasing focus on health and wellbeing, there is an increase in spending on menopausal management and relief products and services. For instance, in July 2023, Slimming Sprinkles launched a comprehensive new online platform designed exclusively for women who are perimenopausal, menopausal, or postmenopausal and experiencing major horm and physiological changes to provide accurate and well-researched information to menopausal women.

Segmental Outlook

The global menopause market is segmented on the component, deployment mode, organization size and industry vertical. Based on the component, the market is sub-segmented into solution, and services. Based on the deployment mode, the market is sub-segmented into on-premise, and cloud. Based on the organization size, the market is sub-segmented into large enterprises, and small & medium sized enterprises. Furthermore, on the basis of industry vertical, the market is sub-segmented into consumer goods and retail, manufacturing, energy and utilities, transport and logistics, aerospace and defense, it and telecom, healthcare and life sciences, and others. The OTC Pharma Products subcategory is expected to capture a significant portion of the market share within the product segment. This can be attributed to pharmaceutical companies' shifting potential of manufacturing OTC medications for the treatment of menopausal symptoms.

The Dietary Supplements Sub-Segment is Anticipated to Hold a Considerable Share of the global Menopause Market

Among the treatment, the dietary supplements sub-segment is expected to hold a considerable share of the global menopause market. The segmental growth is attributed to the consumer preferences. Natural or plant-based therapies have grown more popular, particularly among menopausal women. Supplements that provide multi-system advantages and are produced from natural sources are frequently warmly received by this demographic. For instance, in October 2022, PharmaLinea launched advanced 'whole body' menopause supplement. It offers pain relief in addition benefiting cardio-metabolic, brain, and bone health. Meno Ease' has been found to reduce pain intensity by 27% compared to a placebo. This indicates that it is an effective menopause supplement with potential benefits for various body systems affected by reduced oestrogen levels.

Regional Outlook

The global menopause market is further segmented based on geography including North America (the US, and Canada), Europe (UK, Italy, Spain, Germany, France, and the Rest of Europe), Asia-Pacific (India, China, Japan, South Korea, and Rest of Asia), and the Rest of the World (the Middle East & Africa, and Latin America). Among these, Asia-Pacific is anticipated to hold a prominent share of the market across the globe, owing to category contains both developing and developed economies. Rising healthcare costs are projected to fuel the industry. The development of countries with increasing aging populations, such as Japan, is expected to drive the market in the region.

The North America Region is Expected to Grow at a Significant CAGR in the global Menopause Market

Among all regions, the North America regions is anticipated to grow at a considerable CAGR over the forecast period. Regional growth is attributed to the health and wellness awareness. As individuals have grown health-conscious and seek strategies to preserve a satisfactory standard of life as they age, there is a growing interest in menopause-related health products and services. This trend is propelling the menopausal market forward. According to the Global Public Health, in November 2020, the average age of menopause in industrialized countries is 51 years, and life expectancy is 80.8 years. This means that women spend around one-third of their lifespan in postmenopause. In the US, around 6,000 women reach menopause daily, and approximately 2 million reach menopause every year.

Market Players Outlook

The major companies serving the menopause market includes Bayer AG, Dr.Reddy's Laboratories Ltd, Merck & Co., Inc., Novo Nordisk A/S, Procter & Gambleand others. The market players are considerably contributing to the market growth by the adoption of various strategies including mergers and acquisitions, partnerships, collaborations, funding, and new product launches, to stay competitive in the market. For instance, in November 2022, Northwell Holdings partnered with Aegis Ventures the formation of Upliv, a women's virtual care start-up that desires to set the bar for clinical menopause support. Upliv collaborates with companies to provide virtual telemedicine services in addition to whole-person care to employees suffering from perimenopause and menopausal symptoms.

The Report Covers:

  • Market value data analysis of 2022 and forecast to 2030.
  • Annualized market revenues ($ million) for each market segment.
  • Country-wise analysis of major geographical regions.
  • Key companies operating in the global menopause market. Based on the availability of data, information related to new product launches, and relevant news is also available in the report.
  • Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
  • Analysis of market-entry and market expansion strategies. Competitive strategies by identifying 'who-stands-where' in the market.

Table of Contents

1. Report Summary

  • Current Industry Analysis and Growth Potential Outlook
  • 1.1. Research Methods and Tools
  • 1.2. Market Breakdown
    • 1.2.1. By Segments
    • 1.2.2. By Region

2. Market Overview and Insights

  • 2.1. Scope of the Report
  • 2.2. Analyst Insight & Current Market Trends
    • 2.2.1. Key Findings
    • 2.2.2. Recommendations
    • 2.2.3. Conclusion

3. Competitive Landscape

  • 3.1. Key Company Analysis
  • 3.2. Abbott Healthcare Pvt.ltd.
    • 1.1.1. Overview
    • 1.1.2. Financial Analysis
    • 1.1.3. SWOT Analysis
    • 1.1.4. Recent Developments
  • 3.3. AbbVie
    • 1.1.5. Overview
    • 1.1.6. Financial Analysis
    • 1.1.7. SWOT Analysis
    • 1.1.8. Recent Developments
  • 3.4. At F. Hoffmann-La Roche Ltd
    • 1.1.9. Overview
    • 1.1.10. Financial Analysis
    • 1.1.11. SWOT Analysis
    • 1.1.12. Recent Developments
  • 1.2. Key Strategy Analysis

2. Market Segmentation

  • 2.1. Global Menopause Market by Treatment
    • 2.1.1. Dietary Supplements
    • 2.1.2. OTC Pharma Products
      • 2.1.2.1. *Hormonal
      • 2.1.2.2. *Non-hormonal
  • 2.2. Global Menopause Market by Route of Administration
    • 2.2.1. Topical
    • 2.2.2. Injectable
    • 2.2.3. Oral
  • 2.3. Global Menopause Market by Distribution Channel
    • 2.3.1. Institutional Sales
    • 2.3.2. Retail Sales
    • 2.3.3. Online Sales

3. Regional Analysis

  • 3.1. North America
    • 3.1.1. United States
    • 3.1.2. Canada
  • 3.2. Europe
    • 3.2.1. UK
    • 3.2.2. Germany
    • 3.2.3. Italy
    • 3.2.4. Spain
    • 3.2.5. France
    • 3.2.6. Rest of Europe
  • 3.3. Asia-Pacific
    • 3.3.1. China
    • 3.3.2. India
    • 3.3.3. Japan
    • 3.3.4. South Korea
    • 3.3.5. Rest of Asia-Pacific
  • 3.4. Rest of the World

4. Company Profiles

  • 4.1. Bayer AG
  • 4.2. Bionova
  • 4.3. Biosante
  • 4.4. Church & Dwight Co., Inc.
  • 4.5. Dr.Reddy's Laboratories Ltd.
  • 4.6. Duchesnay
  • 4.7. Eli Lilly and Company India Pvt. Ltd.
  • 4.8. Merck & Co., Inc.
  • 4.9. Novo Nordisk A/S
  • 4.10. Padagis US LLC
  • 4.11. Pfizer
  • 4.12. Procter & Gamble
  • 4.13. Pure Encapsulations
  • 4.14. Teva Pharmaceutical Industries Ltd.
  • 4.15. Theramex HQ UK Ltd.